Behavioral Aging Study and Ethical Lifespan Assessment of Hybrid Mice

Researchers analyzed the behavior of hybrid mice and presented a novel method to qualitatively estimate natural lifespan.

Lifespan stopwatch
Listen to an audio version of this article

Mice are frequently used as research models in aging studies. In 2019, researchers from the University of GothenburgR&D AstraZenecaHarvard Medical School, and Karolinska Institutet identified logistical and ethical issues with the standard system of handling murine models in aging studies. Historically, researchers have favored using male mouse models instead of females, especially in pharmaceutical drug discovery and testing. However, half of the human population is female, and thus, females are half of the recipients of pharmaceuticals on the market. There is a need to fill this gap in research by emphasizing the assessment of both male and female subjects in research studies. The second logistical problem is the use of inbred mice. Inbred laboratory mice tend to have strain-specific behaviors that can skew study results. Therefore, there is a need to replace inbred mice with hybrid mice, especially in behavioral aging studies.

Lastly, the researchers addressed lifespan assessment in mice. Due to ethical concerns, many institutions do not allow researchers to study lifespan in mice. These concerns arose from researchers allowing mice to pass away naturally, even if some mice are terminally ill and suffering. In a research paper published by Aging (Aging-US) in 2019, the researchers came up with a novel method of ethically assessing lifespan. They also employed male and female F2 hybrid mice in a behavioral aging study. Their paper was entitled, “Conclusions from a behavioral aging study on male and female F2 hybrid mice on age-related behavior, buoyancy in water-based tests, and an ethical method to assess lifespan.”

Behavioral Aging Studies in Mice

“In this study, F2 hybrid female and male mice were assessed for behavioral tests with the aim to investigate sex differences and age-related alterations.”

The team used various behavioral tests in order to gain a better understanding of the behavioral effects of aging in female and male F2 hybrid mice. Behavioral tests included an open-field test in an activity box, the shuttle box passive avoidance test, physiological analyses for behavioral phenotyping at seven, 15 and 22 months of age, and a swim test to measure immobility. Immobility in the swim test was an indicator of depressive-like behavior.

In sum, the researchers demonstrated that decreased exploratory behavior is a robust behavioral marker of aging in both male and female hybrid mice. However, altered learning, memory and depressive-like behavior were not significant markers of aging in these models. To this end, the team did not find sex differences in learning or memory using the passive avoidance test. In females, fat mass accounted for 30-46% of the observed increase in depressive-like behavior compared to males.

“This novel finding emphasizes the need to control for body composition in water-based tests.”

Ethical Murine Lifespan Assessment

The ethical method of lifespan assessment the researchers devised involves using estimates of lifespan. In a separate cohort from the behavioral studies, the researchers created this lifespan estimation by separating mice with signs of pain or severe disease from the healthy aging mice. The ill animals were euthanized and then included in two separate data curves. In one curve, the euthanized animals were counted as if their time of death was from natural causes (an underestimation of their lifespan). The researchers then made a second data curve in which they calculated that the euthanized animals as if they had been as healthy as their littermates (an overestimation of their lifespan since the euthanized animals were terminally ill). These curves created an interval that was used as the minimum and maximum lifespan of this cohort. 

“We think this is a really good method that we hope people will start using in lifespan analysis,” said Malin Hernebring, from the University of Gothenburg and R&D AstraZeneca, in a recent Behind the Study interview with Aging-US

Conclusion

The researchers presented a novel method to estimate natural lifespan in survival studies, in which animals in pain or with severe disease are not left to suffer until the end of their natural lifespan. This new method provides a qualitative estimation of natural lifespan, without the expense of animal welfare. The study also showed that F2 hybrid mice are effective in behavioral aging studies, and that fat mass partially accounts for increased immobility in aging female mice. 

The researchers hope that their findings will lead to changes in the way aging research is conducted. In particular, they hope that more emphasis will be placed on testing both male and female subjects, that inbred mice will be replaced with hybrid mice and that their ethical method of lifespan assessment in mouse models is adopted at scale.

“In summary, this work is the first behavioral phenotypic aging study to use hybrid mice and include analyses of both sexes.”

Click here to read the full research paper published by Aging (Aging-US).

AGING (AGING-US) VIDEOS: YouTube | LabTube | Aging-US.com

Aging (Aging-US) is an open-access journal that publishes research papers bi-monthly in all fields of aging research. These papers are available to read at no cost to readers on Aging-us.com. Open-access journals offer information that has the potential to benefit our societies from the inside out and may be shared with friends, neighbors, colleagues, and other researchers, far and wide.

For media inquiries, please contact [email protected].

Trending With Impact: Can Job Stress Cause Epigenetic Aging?

The association between job-related stress and epigenetic aging was investigated using five epigenetic clocks and a Finnish cohort.

Job stress

The Trending With Impact series highlights Aging (Aging-US) publications that attract higher visibility among readers around the world online, in the news, and on social media—beyond normal readership levels. Look for future science news about the latest trending publications here, and at Aging-US.com.

Listen to an audio version of this article

In aging research, recent evidence has encouraged more focus on investigating socioeconomic status (SES) and its role in human health trajectories. Previous studies have used DNA methylation measures and epigenetic clocks to demonstrate a consistent association between low SES and epigenetic age acceleration (EAA). Moreover, researchers have identified a need to further investigate the relationship between SES characteristics and aging.  

“Little is known whether current occupational characteristics or job-related stress – crucial SES characteristics – are associated with EAA.”

Recently, researchers—from Imperial College LondonUniversity of SassariUniversity of Eastern FinlandKarolinska InstitutetUniversity of Oulu, and the Italian Institute for Genomic Medicine—conducted a research study in an effort to help elucidate potential mechanisms by which work characteristics and job stressors may be impacting health and accelerating aging. Their trending research paper was published by Aging (Aging-US) on February 2, 2022, and entitled, “Work-related stress and well-being in association with epigenetic age acceleration: A Northern Finland Birth Cohort 1966 Study.” 

The Study

The researchersin this study included 604 participants from the Northern Finland Birth Cohort 1966. Participants in this cohort were all born in the provinces of Oulu and Lapland, Finland, in 1966. DNA samples were collected and used to determine the relationship between biomarkers of aging, job stress and common environmental factors associated with age acceleration, including obesity, smoking, alcoholism, education status, and physical activity. The team used five different epigenetic clocks as biomarkers of aging: HorvathAA, HannumAA, PhenoAgeAA, GrimAgeAA, and DunedinPoAm.

“In this work, we assessed the association (and its magnitude) of five biomarkers of epigenetic age acceleration with work-related stress and well-being indicators (as well as other employment characteristics) in the Northern Finland Birth Cohort 1966, at 46 years old.”

Participants also filled out a clinical examination questionnaire, a modified Karasek’s Job Content Questionnaire (to assess job strain) and the Occupational Stress Questionnaire (to measure effort-reward imbalance). A number of descriptive statistics were collected from each participant, including body mass index (BMI); educational level; alcohol consumption; smoking habits; physical/leisure activity; job status (employed/unemployed); employer type (private or state/municipality); occupational group (white-collar or blue-collar); and job exposure. The researchers defined “job exposure” as job strain, effort-reward imbalance, overcommitment, occupational physical activity, work-favoring attitude, job security and work engagement, history, hours, and shift. 

The Results

After using linear regression models to analyze the adjusted and unadjusted pooled data (males and females together), the researchers found that job strain was not significantly associated with EAA using any of the epigenetic clocks. All five clocks associated smoking and obesity with accelerated aging (at varying significance). However, alcohol use (even heavy use) was not significantly associated with accelerated aging on any of the clocks. PhenoAgeAA associated job strain, active work and white-collar work (compared to blue-collar) with decreased aging. According to the Hannum and HorvathAA biomarkers of aging, people who worked more than 40 hours per week showed increased EAA.

“Once we stratified analyses by sex, a different pattern of association emerged, with women leading on the statistically significant results.”

Next, the researchers further stratified the results by sex. In men, high-intensity physical effort at work had a decreased aging effect. However, for women, high-intensity physical effort at work had an increased aging effect. The researchers point out that these clocks may have contradictory result due to the fact that women and men often present with diverse, sex-specific epigenetic patterns. While a direct correlation between job stress and epigenetic aging have yet to be proven, the degree of association between work characteristics and biomarkers of epigenetic aging in this study did vary by sex.

Conclusion

“This paper is one of the first attempts to address the working dimension of epigenetic age acceleration indicators, to the best of our knowledge.”

The Northern Finland Birth Cohort 1966 is a useful sample for studying a general population, and many confounders were removed in doing so. However, the researchers were forthcoming about some limitations that remained in this study. The unique characteristics of the cohort, as well as the questionnaires, may be responsible for the results seen in the study. The researchers suggest that additional studies be carried out in other societies and on different types of jobs to account for gender differences. 

“Our results suggest that women and men present different associations with different epigenetic distributions regarding work-related stress indicators.”

Click here to read the full research paper published by Aging (Aging-US).

AGING (AGING-US) VIDEOS: YouTube | LabTube | Aging-US.com

Aging (Aging-US) is an open-access journal that publishes research papers bi-monthly in all fields of aging research. These papers are available to read at no cost to readers on Aging-us.com. Open-access journals offer information that has the potential to benefit our societies from the inside out and may be shared with friends, neighbors, colleagues, and other researchers, far and wide.

For media inquiries, please contact [email protected].

Trending With Impact: ARDD21 Meeting Report Highlights

Read a brief summary of a meeting report from the 8th Annual Aging Research and Drug Discovery (ARDD21) meeting. 

ARDD21

The Trending With Impact series highlights Aging (Aging-US) publications that attract higher visibility among readers around the world online, in the news, and on social media—beyond normal readership levels. Look for future science news about the latest trending publications here, and at Aging-US.com.

Listen to an audio version of this article

The 8th Annual Aging Research and Drug Discovery (ARDD21) meeting was held in Copenhagen, Denmark, from August 30 to September 3, 2021. This meeting was attended by over 130 people on-site, with an additional 1800 people engaged online. The focus of this meeting was the current landscape of aging research and various ways it can be applied to drug discovery. Topics included: age-dependent control of cellular maintenance processes, longevity pathways, artificial intelligence-based drug screening, cellular stress and aging, the benefits of dietary restriction, stem cell rejuvenation, senolytics as an aging therapeutic, diverse models of aging, aging clocks and biomarkers of aging, new ideas in preclinical and clinical aging research, the longevity industry landscape, and a Longevity Medicine Workshop.

In total, there were 75 presentations given at ARDD21 by prominent and dedicated aging researchers. The meeting was thoroughly summarized in a paper published in Aging (Aging-US) Volume 14, Issue 2, entitled, “Meeting Report: Aging Research and Drug Discovery.”

ARDD21 Meeting Report Highlights

One of the keynote presentations was given by Nir Barzilai from the Albert Einstein College of Medicine. He discussed his work on aging and how it can be applied to drug discovery. One interesting finding that he discussed was that many drugs currently used to treat chronic diseases, such as diabetes and heart disease, also have the potential to treat aging. This is due to the fact that many diseases are symptoms of aging, and thus, treating the underlying cause (aging) can in turn treat the symptoms.

Another keynote presentation was given by James Kirkland from the Mayo Clinic. He discussed his work on developing therapies to target senescent cells. Senescent cells can accumulate with age, and their presence has been linked with a variety of age-related conditions such as arthritis, cancer and heart disease. Kirkland’s team has developed a number of potential therapies to eliminate or reduce the number of senescent cells in the body, and he is currently testing them in clinical trials.

Professor Dame Linda Partridge from Max Planck Institute for Biology of Ageing presented on aging and the importance of intestinal homeostasis. Her studies involved rapamycin treatment to act on the longevity pathway mTOR, which revealed that short term and early treatment with rapamycin extends lifespan in D. melanogaster as much as chronic rapamycin treatment. Yu-Xuan Lu, another researcher from the Max Planck Institute for Biology of Ageing, demonstrated the existence of an unconventional intestine sex-specific TORC1-histone axis which uncovers a new aspect of improved longevity with rapamycin.

Brian Kennedy from the Buck Institute for Research on AgingNational University of Singapore and National University Health System showed how Alzheimer’s disease can be used as a model of neuronal aging. Presenting their new WormBot, Matt Kaeberlein from the University of Washington described a “set it and forget it” method of large-scale intervention testing in roundworms (C. elegans). 

“He stressed the importance of broad and unbiased screening of intervention beyond known pathways and in different combinations [56].”

Aging (Aging-US) Editorial Board member Alexey Moskalev from the Russian Academy of Sciences presented on the disruption of hydrogen sulfide homeostasis and its association with aging, and therefore, its potential as a gero-therapeutic target. David Sinclair from Harvard Medical School (also on the Aging Editorial Board) discussed aging-driven epigenetic and gene expression changes in the central nervous system. He showed that this can be safely reversed to restore vision by inducible adeno-associated viruses expressing polycistronic Oct4, Sox2 and Kif4, and that the effect is dependent on DNA demethylation. Finally, a Longevity Medicine Workshop was held with a panel of experts aimed to inspire young students to engage in longevity research. This panel included Aging Editorial Board members Alex Zhavoronkov, Alexey Moskalev and Mikhail Blagosklonny (Editor-In-Chief).

Conclusion

Overall, the ARDD21 meeting was a fruitful exhibition of experts from all areas of aging research that came together to share their latest findings in the field. The highlights in this blog pale in comparison to the thoughtful details included in the original meeting report. 

Click here to read the full meeting report published by Aging (Aging-US).

AGING (AGING-US) VIDEOS: YouTube | LabTube | Aging-US.com

Aging (Aging-US) is an open-access journal that publishes research papers bi-monthly in all fields of aging research. These papers are available to read at no cost to readers on Aging-us.com. Open-access journals offer information that has the potential to benefit our societies from the inside out and may be shared with friends, neighbors, colleagues, and other researchers, far and wide.

For media inquiries, please contact [email protected].

Trending With Impact: Therapeutic Strategy Improves Cell Senescence

In the cover paper of Aging (Aging-US) Volume 14, Issue 2, researchers discovered a potential therapeutic strategy to target senescent cells and combat aging and age-related diseases.

The Trending With Impact series highlights Aging (Aging-US) publications that attract higher visibility among readers around the world online, in the news, and on social media—beyond normal readership levels. Look for future science news about the latest trending publications here, and at Aging-US.com.

Listen to an audio version of this article

Cellular senescence appears to be a phenomenon fundamentally ingrained within the aging process and linked to age-related diseases. Characterized broadly by permanent cessation of the cell cycle, cellular senescence may not be as permanent as once thought. 

Researchers from Incheon National University and Korea University conducted a new study exploring analogs of oxazoloquinoline and their potential to alleviate cellular senescence. Their trending research paper was published as the cover of Aging (Aging-US) Volume 14, Issue 2, and entitled, “Targeting regulation of ATP synthase 5 alpha/beta dimerization alleviates senescence.”

THE STUDY

Adenosine triphosphate (ATP) is an energy-carrying molecule found in all living cells. In order to meet the energy demands of the cell, the primary function of the mitochondria is to produce ATP. The maintenance of mitochondrial metabolism is inseparably linked with the regulation of senescence. Therefore, dysfunctional mitochondria has been considered as both a target and the cause of senescence. In addition to a marked decrease in ATP production, senescent cells also increase the expression of inflammatory cytokines, including interleukin 33, or IL-33. The researchers believe that reducing IL-33 may be a possible intervention to reduce senescence in aging patients and age-related diseases.

“In this study, using in-house compound library containing 20 oxazoloquinoline analogs designed to IL-33 inhibitors [9], we aimed to identify compounds capable of ameliorating senescence.”

The researchers investigated 20 oxazoloquinoline analogs using in vitro assays of senescent human diploid fibroblasts and embryonic kidney cells. Efficacy of the candidate compounds was determined using a screening strategy to measure their capacity to increase cell number. Cell numbers were measured between zero and 20 days after compound exposure. The researchers also measured indicators including mitochondrial membrane potential, reactive oxygen species (ROS) levels and p21 expression. They found that the analog KB1541 led to the maximum cell number increase, the recovery of mitochondrial function and the alleviation of cellular senescence. The researchers suggest that KB1541 could be a promising therapeutic agent for use in aging-related diseases.

“The increase in mitochondrial cristae length by KB1541 could be explained by previous findings showing that the increase in ATP generation exerted beneficial effects in mitochondrial function including increases in calcium buffering capacity and decrease in overall ROS production [48].”

CONCLUSIONS

“Taken together, our study provides evidence that the fine-tuning of ATP synthase 5 alpha/beta dimerization by KB1541 can induce mitochondrial functional recovery, concomitant recovery of senescent phenotypes, rendering the use of KB1541 as a potentially advantageous therapeutic strategy in aging and age-related diseases.”

The authors acknowledged that further studies are needed to clarify the exact relationship between IL-33 and mitochondrial energy metabolism. Further studies are also needed to investigate whether other IL-33 inhibitors can modulate senescence by the mechanisms found in the study. This research provides valuable insight into the potential of oxazoloquinoline analogs as novel therapeutic agents for aging and age-related diseases. With further exploration, their findings could lead to new therapeutic strategies to combat aging.

“The role of IL-33 in senescence is not clearly elucidated, therefore discovery of a novel interacting partner will provide clues toward revealing its function.”

Click here to read the full research paper published by Aging (Aging-US).

AGING (AGING-US) VIDEOS: YouTube | LabTube | Aging-US.com

Aging (Aging-US) is an open-access journal that publishes research papers bi-monthly in all fields of aging research. These papers are available to read at no cost to readers on Aging-us.com. Open-access journals offer information that has the potential to benefit our societies from the inside out and may be shared with friends, neighbors, colleagues, and other researchers, far and wide.

For media inquiries, please contact [email protected].

Aging’s Top 10 Most-Viewed Papers in 2021

Aging's Top 10 papers of 2021

Read the 10 most-viewed papers on Aging-US.com of 2021.

Listen to an audio version of this post

#10: Iron: an underrated factor in aging

Author: Dennis Mangan

Institution: MTOR LLC

Quote: “Blocking iron absorption through drugs or natural products extends lifespan. Many life-extending interventions, such as rapamycin, calorie restriction, and old plasma dilution can be explained by the effects they have on iron absorption, excretion, and metabolism.”


#9: Reversal of cognitive decline: A novel therapeutic program

Author: Dale E. Bredesen

Institutions: University of California Los Angeles and Buck Institute for Research on Aging

Quote: “This report describes a novel, comprehensive, and personalized therapeutic program that is based on the underlying pathogenesis of Alzheimer’s disease, and which involves multiple modalities designed to achieve metabolic enhancement for neurodegeneration (MEND).”


#8: Shorter telomere lengths in patients with severe COVID-19 disease

Authors: Raul Sanchez-Vazquez, Ana Guío-Carrión, Antonio Zapatero-Gaviria, Paula Martínez, and Maria A. Blasco

Institutions: Spanish National Cancer Research Center – CNIO and Field Hospital COVID-19, IFEMA

Quote: “The incidence of severe manifestations of COVID-19 increases with age with older patients showing the highest mortality, suggesting that molecular pathways underlying aging contribute to the severity of COVID-19. One mechanism of aging is the progressive shortening of telomeres, which are protective structures at chromosome ends.”


#7: Hyperbaric oxygen therapy alleviates vascular dysfunction and amyloid burden in an Alzheimer’s disease mouse model and in elderly patients

Authors: Ronit Shapira, Amos Gdalyahu, Irit Gottfried, Efrat Sasson, Amir Hadanny, Shai Efrati, Pablo Blinder, and Uri Ashery 

Institutions: Tel Aviv University and Assaf Harofeh Medical Center

Quote: “Hyperbaric oxygen therapy (HBOT) is in clinical use for a wide range of medical conditions. In the current study, we exposed 5XFAD mice, a well-studied AD model that presents impaired cognitive abilities, to HBOT and then investigated the therapeutical effects using two-photon live animal imaging, behavioral tasks, and biochemical and histological analysis.”


#6: Fighting the storm: could novel anti-TNFα and anti-IL-6 C. sativa cultivars tame cytokine storm in COVID-19?

Authors: Anna Kovalchuk, Bo Wang, Dongping Li, Rocio Rodriguez-Juarez, Slava Ilnytskyy, Igor Kovalchuk, and Olga Kovalchuk

Institutions: Pathway Research Inc.University of Calgary and University of Lethbridge

Quote: “Cannabis sativa has been proposed to modulate gene expression and inflammation and is under investigation for several potential therapeutic applications against autoinflammatory diseases and cancer. Here, we hypothesized that the extracts of novel C. sativa cultivars may be used to downregulate the expression of pro-inflammatory cytokines and pathways involved in inflammation and fibrosis.”


#5: Examining sleep deficiency and disturbance and their risk for incident dementia and all-cause mortality in older adults across 5 years in the United States

Authors: Rebecca Robbins, Stuart F. Quan, Matthew D. Weaver, Gregory Bormes, Laura K. Barger, and Charles A. Czeisler

Institutions: Brigham and Women’s HospitalHarvard Medical School and Boston College

Quote: “Sleep disturbance and deficiency are common among older adults and have been linked with dementia and all-cause mortality. Using nationally representative data, we examine the relationship between sleep disturbance and deficiency and their risk for incident dementia and all-cause mortality among older adults.”


#4: Rejuvant®, a potential life-extending compound formulation with alpha-ketoglutarate and vitamins, conferred an average 8 year reduction in biological aging, after an average of 7 months of use, in the TruAge DNA methylation test

Authors: Oleksandr Demidenko, Diogo Barardo, Valery Budovskii, Robb Finnemore, Francis R. Palmer III, Brian K. Kennedy, and Yelena V. Budovskaya

Institutions: TruMe Inc.National University SingaporePonce de Leon HealthNational University Health System Singapore, and Singapore Institute for Clinical Sciences, A*STAR

Quote: “Instead, aging biomarkers, such as DNA methylation (DNAm) clocks, have been developed to monitor biological age. Herein we report a retrospective analysis of DNA methylation age in 42 individuals taking Rejuvant®, an alpha-ketoglutarate based formulation, for an average period of 7 months.”


#3: Aging and rejuvenation – a modular epigenome model

Authors: Priscila Chiavellini, Martina Canatelli-Mallat, Marianne Lehmann, Maria D. Gallardo, Claudia B. Herenu, Jose L. Cordeiro, James Clement, and Rodolfo G. Goya

Institutions: National University of La PlataNational University of CordobaWorld Academy of Art and Science (WAAS), and Betterhumans Inc.

Quote: “The view of aging has evolved in parallel with the advances in biomedical sciences. Long considered as an irreversible process where interventions were only aimed at slowing down its progression, breakthrough discoveries like animal cloning and cell reprogramming have deeply changed our understanding of postnatal development, giving rise to the emerging view that the epigenome is the driver of aging.”


#2: Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial

Authors: Kara N. Fitzgerald, Romilly Hodges, Douglas Hanes, Emily Stack, David Cheishvili, Moshe Szyf, Janine Henkel, Melissa W. Twedt, Despina Giannopoulou, Josette Herdell, Sally Logan, and Ryan Bradley

Institutions: Institute for Functional MedicineAmerican Nutrition AssociationNational University of Natural MedicineAriel UniversityMcGill University, and University of California San Diego

Quote: “Manipulations to slow biological aging and extend healthspan are of interest given the societal and healthcare costs of our aging population. Herein we report on a randomized controlled clinical trial conducted among 43 healthy adult males between the ages of 50-72.”


#1: Hyperbaric oxygen therapy increases telomere length and decreases immunosenescence in isolated blood cells: a prospective trial

Authors: Yafit Hachmo, Amir Hadanny, Ramzia Abu Hamed, Malka Daniel-Kotovsky, Merav Catalogna, Gregory Fishlev, Erez Lang, Nir Polak, Keren Doenyas, Mony Friedman, Yonatan Zemel, Yair Bechor, and Shai Efrati

Institutions: Shamir Medical CenterTel Aviv University and Bar Ilan University

Quote: “At the cellular level, two key hallmarks of the aging process include telomere length (TL) shortening and cellular senescence. Repeated intermittent hyperoxic exposures, using certain hyperbaric oxygen therapy (HBOT) protocols, can induce regenerative effects which normally occur during hypoxia. The aim of the current study was to evaluate whether HBOT affects TL and senescent cell concentrations in a normal, non-pathological, aging adult population.”


Click here to read the latest papers published by Aging.

AGING (AGING-US) VIDEOS: YouTube | LabTube | Aging-US.com

Aging (Aging-US) is an open-access journal that publishes research papers bi-monthly in all fields of aging research. These papers are available to read at no cost to readers on Aging-us.com. Open-access journals offer information that has the potential to benefit our societies from the inside out and may be shared with friends, neighbors, colleagues, and other researchers, far and wide.

For media inquiries, please contact [email protected].

Trending With Impact: Are Our Muscles Intrinsically Impaired by Aging?

In a priority research paper published by Aging-US in January of 2022, researchers investigated aged muscle stem cells and their ability to sense and respond to mechanical cues.

Listen to an audio version of this article
3D Illustration of muscle tissue
3D Illustration of muscle tissue

The Trending With Impact series highlights Aging (Aging-US) publications that attract higher visibility among readers around the world online, in the news, and on social media—beyond normal readership levels. Look for future science news about the latest trending publications here, and at Aging-US.com.

IIs muscle wasting a fate humans can avoid, or will the problem of aging-related muscle loss only be resolved when the mystery of aging is solved? Researchers—from Vrije Universiteit AmsterdamUniversity of AmsterdamSorbonne UniversitéAmsterdam University Medical Center VUmcUniversité Catholique de LouvainKU Leuven, and Institut NeuroMyoGène—conducted a study aimed at elucidating whether muscle stem cells are inherently impaired by the aging process in their ability to sense and respond to mechanical cues. Their priority research paper was published in January of 2022 on the cover of Aging (Aging-US) Volume 14, Issue 1, and entitled, “Reduced growth rate of aged muscle stem cells is associated with impaired mechanosensitivity.”

Muscle Stem Cells

Muscle stem cells (MuSCs) are stem cells located within skeletal muscle tissues. MuSCs function to repair Muscle stem cells (MuSCs) are stem cells located within skeletal muscle tissues. MuSCs function to repair damaged myofibers and give rise to new skeletal muscle cells. These self-renewing stem cells are involved in muscle growth, repair and regeneration. As we age, MuSCs decline in number and lose their potential to regenerate damaged myofibers, leading to sarcopenia. The researchers in this study hypothesized that the responsiveness of aged MuSCs is impared by the aging process both physically and mechanically.

“We postulated that aged MuSCs are intrinsically impaired in their responsiveness to omnipresent mechanical cues through alterations in MuSC morphology, mechanical properties, and number of integrins, culminating in impaired proliferative capacity.”

The Study

The researchers assessed whether aged MuSCs become impaired in their ability to proliferate, respond to pulsating fluid shear stress (PFSS) mechanical loading, maintain focal adhesion number and/or size after mechanical loading, and in their ability to express the protein-coding gene Integrin Subunit Alpha 7 (ITGA7). 

“Integrins are transmembrane protein receptors that connect MuSCs to the ECM [extracellular matrix] components and are part of focal adhesions [51].”

Young MuSCs (2 months) and aged MuSCs (22 months) were isolated from male mice. Fluorescence-activated cell purification was carried out and cells were cultured. To measure proliferation, images were captured of the cell cultures every 24 hours. Images were also taken pre- and post-PFSS to determine the number of young and aged MuSCs detached from the culture media (focal adhesion) as a result of PFSS treatment. Since nitric oxide (NO) is known to play a role in MuSC activation and muscle regeneration, NO analysis was conducted to measure NO production. To determine MuSC morphology, the researchers carried out immunohistochemistry staining. They also measured MuSC stiffness, deformation, gene expression, and RNA isolation and reverse transcription.

Compared to young MuSCs, the researchers found aged MuSCs had impaired growth. Their results showed that IL-6 gene expression was lower in aged MuSCs, which suggested that aged MuSCs were intrinsically altered in the signaling pathways governing proliferation and MuSC function. Aged MuSCs showed an increase in cell volume and reduced cell adhesion after mechanical loading. NO levels in young and aged MuSCs were similar, and PFSS in both cultures resulted in similar increases in NO production. The researchers found decreased ITGA7 expression and reduced pPXN clusters (focal adhesion formation) were involved in altered MuSC function with age. High YAP nuclear localization was found in aged MuSCs, as well as reduced mechanosensitivity.

“Aged MuSCs were less sensitive to shear forces and showed upregulation of less genes, suggesting that the decreased mechanosensitivity was due to decreased integrin protein expression, i.e. ITGA7, ITGA5, and ITGB5, and focal adhesion number.”

Conclusion

The results from this study found that aged MuSCs were intrinsically impaired in their growth rate due to decreased ITGA7 expression and diminished focal adhesion formation. These changes coincided with increased cell volume, decreased MuSC adhesion, altered mechanosensitivity, changed YAP signaling and decreased expression of several genes (including cell cycle genes). The researchers suggest that ITGA7 and pPXN may be potential therapeutic targets to improve aged MuSC function.

“As an implication, a possible therapeutic option could be restoration ITGA7 and focal adhesion number in aged MuSCs, which may help to restore MuSCs adhesion to their niche as well as growth rate of these cells.”

Click here to read the full priority research paper published by Aging (Aging-US).

AGING (AGING-US) VIDEOS: YouTube | LabTube | Aging-US.com

Aging (Aging-US) is an open-access journal that publishes research papers bi-monthly in all fields of aging research. These papers are available to read at no cost to readers on Aging-us.com. Open-access journals offer information that has the potential to benefit our societies from the inside out and may be shared with friends, neighbors, colleagues, and other researchers, far and wide.

For media inquiries, please contact [email protected].

Trending With Impact: Hair Follicles May Replace Traditional Biopsies

A new device has been developed by researchers to efficiently and painlessly collect hair follicle tissue samples from laboratory mammals, and even humans.

Figure 6. Markers of senescence analysis in hair follicular cells.
Figure 6. Markers of senescence analysis in hair follicular cells.

The Trending With Impact series highlights Aging (Aging-US) publications that attract higher visibility among readers around the world online, in the news, and on social media—beyond normal readership levels. Look for future science news about the latest trending publications here, and at Aging-US.com.

Laboratory mammals have impacted human-kind far beyond enhancing scientific knowledge in behavioral and environmental research. These animals have greatly contributed to human healthspan and lifespan in countless ways; from validating life-saving cancer therapies to accelerating the future of human anti-aging and longevity interventions. With respect for these salubrious animals, ethical standards (per country) require that researchers handle laboratory mammals with care, and that pain and stress are minimized. Blood and skin tissue samples (biopsies) collected from animals should be replaced whenever possible. For the researchers, this twofold invasive procedure for the animals is also time- and resource-limiting—presenting a bottleneck in the biomedical research process.

“However, we present here a simple method for obtaining biological material in the form of follicular cells from laboratory mice with sufficient quantities and quality for multiple analyses using standard modern molecular biology methods.”

In an effort to efficiently and humanely solve this ethics/logistics problem, researchers—from Palacky UniversityUniversity Hospital OlomoucDanish Cancer Society Research Center, and Karolinska Institute—developed a novel, non-invasive device that can be used to collect tissue samples from hair follicles. They tested the applications of this device and authored a research paper of the study. In December of 2021, their paper was published on the cover of Aging (Aging-US) Volume 13, Issue 23, and entitled, “An efficient, non-invasive approach for in-vivo sampling of hair follicles: design and applications in monitoring DNA damage and aging.”

“As millions of laboratory mice are routinely genotyped globally every year this approach represents a major ethical and logistic breakthrough.”

The Follicular Cells’ Collector

As opposed to traditional biopsies, hair follicle collection is a humane, easy, non-invasive, and painless method of DNA and tissue sample collection. Each hair follicle contains approximately 50 cells—of various cell types. 

“This micro-organ structure also has other advantages in biomarker studies, including suitability for investigations of circadian rhythms [57], and the presence of numerous cell types in a small area, which can be easily distinguished, such as keratinocytes, melanocytes, or perifollicular macrophages and mast cells [810].”

Previously, the limitations of using hair follicles as DNA and tissue samples stemmed from ineffective technology. Many devices involved ordinary tweezers and forceps with high risks for cross-contamination. The researchers termed their novel tissue sample collection device the “follicular cells’ collector.” The follicular cells’ collector is designed with dual pipettes and utilizes a precision vacuum method of hair follicle extraction. The device can be used to comfortably collect DNA and tissue samples from laboratory mammals, and even from humans. 

“Although hair samples have been previously used for that purpose [2931], our sample collection approach may motivate researchers to use them more routinely and widely.”

The Study

To validate that these hair follicle samples contain the required genetic information necessary in most studies, researchers compared murine genotyping results of 151 tail biopsies and 151 hair samples. In order to determine the ability of these samples to detect changes in expression patterns induced by external factors, the team also observed the DNA damage response in hair follicle cells after gamma irradiation and after the topical application of chemical clastogens. Further exploring its potential application in aging research, researchers assayed expression patterns of selected markers of biological age and senescence in murine hair follicular cells. The researchers conducted many other tests and experiments using murine hair follicular cells in this study.

“The speed by which the samples can be collected and processed (e.g. by fixation) is among the biggest advantages of our solution as it can be performed within seconds. This fact limits any potential underlying cellular responses and additional DDR [DNA damage response] caused by cofounding stressing factors related to the withdrawal process [2].”

Conclusion

The researchers found that the follicular cells’ collector method of obtaining mouse hair follicular cells can be successfully used for genotyping, quantitative polymerase chain reaction testing and quantitative immunofluorescence. They also demonstrated that this method can successfully monitor quality and expression level changes of selected proteins—induced by external factors and during natural or experimentally induced aging. 

“Our results highlight the value of hair follicles as biological material for convenient in vivo sampling and processing in both translational research and routine applications, with a broad range of ethical and logistic advantages over currently used biopsy-based approaches.”

Click here to read the full research paper published by Aging (Aging-US).

AGING (AGING-US) VIDEOS: YouTube | LabTube | Aging-US.com

Aging (Aging-US) is an open-access journal that publishes research papers bi-monthly in all fields of aging research and other topics. These papers are available to read at no cost to readers on Aging-us.com. Open-access journals offer information that has the potential to benefit our societies from the inside out and may be shared with friends, neighbors, colleagues, and other researchers, far and wide.

For media inquiries, please contact [email protected].

Trending With Impact: Aging Reduced by 8 Years With Rejuvant®

A recent study revealed that participants experienced an average 8 year reduction in biological aging after taking Rejuvant® for approximately 7 months.

Anti-aging hourglass

The Trending With Impact series highlights Aging (Aging-US) publications that attract higher visibility among readers around the world online, in the news, and on social media—beyond normal readership levels. Look for future science news about the latest trending publications here, and at Aging-US.com.

Listen to an audio version of this article

Waiting until the end of a subject’s lifespan is quite a leaden method of validating the efficacy of a longevity-based intervention. This method could take researchers generations upon generations to eventually validate an effective intervention—or—this method might not ever yield results seen by the general public. However, researchers may have devised an innovative way to solve this problem.

“If we hope to control the aging process, we need to learn how to measure the rate of aging in shorter time periods.”

Many researchers believe that measuring the rate of human aging can be done faster by using DNA methylation-based aging clocks. Methylation-based clocks are capable of determining human biological aging with impressive accuracy. Hypermethylated and demethylated regions of DNA (CpG islands near specific aging-associated genes) play a key role in turning certain genes on and off throughout the aging process. Therefore, methylation is a biomarker of aging. While there is a short list of currently available biological aging clocks for researchers to use in studies of anti-aging therapies, the TruAge DNA methylation test is preferable in some cases, due to its accessibility, use of simple saliva samples and cost effectiveness.

“For the first time, these biomarkers of aging give scientists the opportunity to study the effects of anti-aging compounds in real-time and directly in humans.”

In a new study, researchers from TruMe LabsNational University of Singapore and Ponce de Leon Health used the TruAge DNA methylation test to validate Rejuvant®—a patent-pending anti-aging dietary supplement. The trial study yielded unprecedented results and the research paper authored by the team was published as the cover of Aging (Aging-US) Volume 13, Issue 22, entitled: “Rejuvant®, a potential life-extending compound formulation with alpha-ketoglutarate and vitamins, conferred an average 8 year reduction in biological aging, after an average of 7 months of use, in the TruAge DNA methylation test”.

The Study

Developed at Ponce de Leon Health, Rejuvant® is composed primarily of a compound called Alpha-Ketoglutarate (AKG). This molecule is naturally produced in humans and functions as a signaling molecule, an energy donor, a precursor to amino acid biosynthesis, and a regulator of epigenetic processes. In humans and other animals, AKG levels gradually decrease with age. Other components of Rejuvant® are calcium and, for males and females, Vitamin A and Vitamin D, respectively. 

“The goal of the study was to determine the effect of Rejuvant® supplementation on human biological aging by measuring DNA methylation.”

Researchers enrolled 42 healthy participants who were on average 64 years of age (43 to 72). Before taking Rejuvant®, all 42 participants completed a survey and their baseline biological age was measured using the TruMe age prediction model. The survey was a self-reported questionnaire including information about diet, alcohol intake, previous consumption of Rejuvant®, health, height and weight, sleep duration, smoking status, exercise frequency, physical activity level, meal frequency, snacking frequency, number of additional dietary supplements consumed and frequency, hair status, education, healthy lifestyle mindset, and trust in dietary supplements. 

Participants (majority male; 28) took two tablets of Rejuvant® daily, for a duration of four to 10 months. Biological age was measured from saliva samples again after taking Rejuvant® for four to 10 months. At the end of the trial, participants completed the same survey. The researchers compared the baseline surveys with the final surveys to check for other confounders contributing to the results in the study. They also used the surveys to select a sub-group of 13 participants who reported no change in diet type, drinking frequency, additional dietary supplements intake, sleep duration, and exercise frequency. They compared this sup-group with the rest of the cohort. They also compared results between males and females, older and younger participants, and participants with higher biological age relative to their chronological age (aging more quickly).

Results and Conclusion

Researchers examined associations between the epigenetic clock, health status, physical fitness, and the effects of Rejuvant® on human biological aging. The researchers were forthcoming about limitations in this study. A control arm was not used, the cohort was relatively small, only one biological aging clock was used, and researchers did not collect other kinds of data relevant to aging. However, the study results showed that Rejuvant® conferred an average eight year reduction in biological aging after approximately seven months of use. The 13 participants in the sub-group saw anti-aging benefits slightly less than the rest of the cohort. Rejuvant® was more effective in chronologically older participants and in participants that were aging more quickly (with a higher biological age relative to their chronological age).

“Future randomized clinical trials will be required to confirm the findings presented here. Nevertheless, the results in this manuscript suggest that Rejuvant® may have significant effects on biological age as measured by DNA methylation of saliva samples.”

Click here to read the full priority research paper published by Aging (Aging-US).

WATCH: AGING VIDEOS ON LABTUBE

Aging (Aging-US) is an open-access journal that publishes research papers monthly in all fields of aging research and other topics. These papers are available to read at no cost to readers on Aging-us.com. Open-access journals offer information that has the potential to benefit our societies from the inside out and may be shared with friends, neighbors, colleagues, and other researchers, far and wide.

For media inquiries, please contact [email protected].

Trending With Impact: Worms Reveal Early Event in Neurodegeneration

Researchers examined roundworms to determine the role of mitochondrial dysfunction in progressive neurodegenerative disorders, such as Alzheimer’s disease.

From Figure 2. Altered mitochondrial morphology and activity in tauwt-expressing larvae. (truncated)
From Figure 2. Altered mitochondrial morphology and activity in tauwt-expressing larvae. (truncated)

The Trending With Impact series highlights Aging (Aging-US) publications that attract higher visibility among readers around the world online, in the news, and on social media—beyond normal readership levels. Look for future science news about the latest trending publications here, and at Aging-US.com.

Listen to an audio version of this article

Many aging-associated neurodegenerative disorders, including Alzheimer’s disease, involve the aggregation of abnormal tau in nerve cells (neurons). Normally, tau proteins function to stabilize microtubules in the brain. Tauopathy occurs when tau proteins become misfolded and misshapen (which turns tau into toxic tau). They then continue to proliferate and bind to each other, forming tau oligomers. These tau oligomers are more toxic and have a greater potential to spread tau pathology. Before the tau pathology snowballs into neurodegenerative disorders, the events that lead up to abnormal tau have remained elusive to researchers. 

“While the association between tau levels and energy metabolism is established, it is not clear whether mitochondrial dysfunction is an early pathological feature of high levels of tau or a consequence of its excessive formation of protein aggregates.”

Previous studies have demonstrated an association between tau levels and mitochondrial metabolism, however, determining which one proceeds the other has yet to be fully illuminated. Shedding light on this subject, researchers—from the University of CopenhagenNational and Kapodistrian University of Athens and the National Institutes of Health’s National Institute on Aging—used a Caenorhabditis elegans (C. elegans; roundworm/nematode) model of tau to examine mitochondrial changes over time. Their paper was chosen as the cover of Aging (Aging-US) Volume 13, Issue 21, published in November of 2021 and entitled, “Alteration of mitochondrial homeostasis is an early event in a C. elegans model of human tauopathy”.  

The Study

“Here, we utilized transgenic nematodes expressing the full length of wild type tau in neuronal cells and monitored mitochondrial morphology alterations over time.”

To investigate the impact of tau on mitochondrial activity, neuronal function and organismal physiology, the researchers selected and cultured an already characterized nematode strain that expresses the full length of wild type human tau protein. They compared wild type nematodes with tau-expressing nematodes (at various ages) over time using a thrashing assay, mitochondrial imaging, worm tracking software, and western blot analysis. Calcium deregulation was also examined to determine whether or not it is implicated in the impairment of mitochondrial activity in the tau-expressing nematodes. They found that chelating calcium led to restored mitochondrial activity and suggested a link between mitochondrial damage, calcium homeostasis and neuronal impairment in this nematode model.

Figure 2. Altered mitochondrial morphology and activity in tauwt-expressing larvae.
Figure 2. Altered mitochondrial morphology and activity in tauwt-expressing larvae.

Conclusion

“Our findings suggest that defective mitochondrial function is an early pathogenic event of tauopathies, taking place before tau aggregation and undermining neuronal homeostasis and organismal fitness.”

The researchers were forthcoming about limitations in their study, given the differences between human and nematode biology and pathology. Nevertheless, they found evidence that, in this nematode tauopathy model, neurotoxicity depends on protein alterations and mitochondrial dysfunction. Mitochondrial dysfunction takes place before high levels of tau are detected. Tau mutations may also modulate calcium homeostasis by influencing the main cellular storage sites—the endoplasmic reticulum and mitochondria.

“Investigating the tight interplay between tau oligomers and energy metabolism will enlighten new avenues for therapeutic strategies to slow or halt the progression of dementia-related diseases such as AD [Alzheimer’s disease].”

Click here to read the full priority research paper published by Aging (Aging-US).

WATCH: AGING VIDEOS ON LABTUBE

Aging (Aging-US) is an open-access journal that publishes research papers monthly in all fields of aging research and other topics. These papers are available to read at no cost to readers on Aging-us.com. Open-access journals offer information that has the potential to benefit our societies from the inside out and may be shared with friends, neighbors, colleagues, and other researchers, far and wide.

For media inquiries, please contact [email protected].

Trending With Impact: Retired Sled Dogs in Aging Research

Researchers adopted 103 retired sled dogs for a longitudinal study on canine aging that may one day be used to increase human healthspan and longevity.

sled dogs

The Trending With Impact series highlights Aging (Aging-US) publications that attract higher visibility among readers around the world online, in the news, and on social media—beyond normal readership levels. Look for future science news about the latest trending publications here, and at Aging-US.com.

Listen to an audio version of this article

Whether they are sprinters or distance runners, sled dogs are known for their competitive nature and athletic prowess. With age, however, these athletes eventually run out of steam—just as humans inevitably do. Canines of all breeds are affected by aging, including a loss of resilience, accumulation of molecular damage and age-related diseases. These relatively short-lived, large mammals are one of the few to share environments with humans, and even have access to advanced medical care. Many believe the canine aging process resembles human aging the closest compared to any other animal. 

A team of scientists—from Cornell UniversityNorth Carolina State UniversityTauber Bioinformatic Research Center, and Roswell Park Comprehensive Cancer Center—saw the opportunities and advantages of studying canine aging in a controlled environment. Co-founders Andrei Gudkov, PhD, Dr Sci, Katerina Andrianova, PhD, and Daria Fleyshman, PhD, established a non-profit organization called Vaika Inc. In 2018, Vaika allowed these researchers to begin collaborating in a longitudinal study on the mechanisms of aging among 103 retired sled dogs. The researchers authored a trending research perspective about the details of their long-term study. In September 2021, their paper was published on the cover of Aging (Aging-US)’s Volume 13, Issue 18, and entitled, “Development of infrastructure for a systemic multidisciplinary approach to study aging in retired sled dogs.”

THE STUDY

The researchers chose to adopt retired sled dogs for this study in particular for a variety of reasons: 1) Based on the type of events they partake in, sled dogs usually have a record of health and performance that can be used for reference as they age. 2) Sled dogs are selected for performance, but are not limited to a particular breed and can be crossbred. This provides a somewhat homogeneous population to study while being less prone to breed-specific biases. 3) Sled dogs are used to working with many handlers, therefore, the transition into the kennel/research facility may be easier for them to adjust to. 4) Over their career, these dogs have been exposed to environmental pathogens in frequent group interactions. This provides the researchers a sufficient immune system model to study. 5) Sled dogs are used to living in packs, but forming short-term bonds—making them adaptable to living with a variety of handlers in a population of 103 other dogs. 

“Thus, it is essential to establish a reference set of ‘healthy aging’ parameters specifically for each dog model, and we see this as one of the main goals of our sled dog study.”

The optics of caring for 103 retired sled dogs between the ages of eight and 11 (when the study began) may initially sound problematic, but all indications suggest that these dogs are living better than many humans. Their 8,254-square foot kennel is located on the Baker Institute campus of the College of Veterinary Medicine at Cornell University. The researchers designed the study so that the dogs are thoroughly examined, observed, fed, socialized, exercised, vaccinated and anything else they may need. The dogs’ personalities and special needs are taken into consideration when cohabitating with other dogs, in their separate rooms and during playtime outside. They have in-house veterinarians and researchers to monitor their health. Importantly, the researchers are monitoring not only the dogs’ health but also parameters of their individual aging experience.

“Our goal is not just to assess the state of health of a given dog but rather to dissect the aging process into its two key components: (i) declining resilience and (ii) acquisition of aging-related diseases.”

In order to observe declining resilience and aging-related diseases, the dogs participate in regular physical fitness (treadmill and pull tests) and cognitive tests (handler questionnaires, β-amyloid plaques, brain atrophy, neuron loss, and etc.). Their performance and scores are measured and compared to their previous scores. The researchers also regularly collect blood samples to assess the dogs for somatic cell genome modifications (accumulation of DNA damage) and immune system status (immunosenescence).

“In general, the canine immune system undergoes similar age-related changes to that of humans [85]. However, since completed canine studies are generally less comprehensive and predominantly cross-sectional, the reliability and relative significance of various immune parameters in aging have yet to be characterized.”

CONCLUSION

This research is still ongoing, and the researchers believe the infrastructure they established in this sled dog study is an important advancement in aging research. In the future, this animal model may be used to test anti-aging therapies and translate into advancing human healthspan and lifespan.

“We expect that these analyses will allow us to (i) characterize the mechanism(s) and regulation of canine aging, (ii) identify parameters and biomarkers suitable for assessment of biological age, and (iii) define factors that may act as aging accelerators or decelerators.”

Click here to read the full research perspective, published by Aging (Aging-US).

WATCH: AGING VIDEOS ON LABTUBE

Aging (Aging-US) is an open-access journal that publishes research papers twice a month—in all fields of aging research and other biomedical topics. These papers are available to read at no cost to readers on Aging-us.com. Open-access journals offer information that has the potential to benefit our societies from the inside out and may be shared with friends, neighbors, colleagues, and other researchers, far and wide.

For media inquiries, please contact [email protected].

  • Follow Us